Medical Advisory Committee
Ann M. Reed, M.D.
Professor of Medicine and Pediatrics
Ann M. Reed, M.D., is chair of the Department of Pediatric and Adolescent Medicine at Mayo Clinic. She is a consultant in the Division of Rheumatology in the Department of Internal Medicine with a joint appointment in the Division of Pediatric Rheumatology in the Department of Pediatric and Adolescent Medicine. She has master’s faculty privileges in Clinical & Translational Science at Mayo Graduate School.
Dr. Reed received the B.A. degree in biology/zoology from the University of Kentucky and the M.D. degree from Medical College of Ohio. She completed an internship and residency in pediatrics at Children’s Hospital Medical Center of Akron and a fellowship in clinical immunology/rheumatology at Children’s Memorial Hospital in Chicago. She further completed a fellowship in the Division of Immunology/Rheumatology in the Department of Pediatrics at Northwestern University Medical School and a research fellowship in a molecular genetics laboratory at the University of Chicago.
Her work has helped to identify genes that predispose children to Juvenile Dermatomyositis (JDM) and to give a comprehensive understanding of the genetics of the disease. Her work also involves early detection and diagnosis with personalized treatment for JDM including improved markers of disease activity and prediction of treatment response. She is involved in international multicenter clinical trials which are working to establish outcome measures for JDM disease activity and chronicity and look for new agents to treat the disease in both adults and children. Dr. Reed is principal investigator on several research grants funded by the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Her findings have been published in peer-reviewed journals such as Journal of Immunology, Muscle Nerve, The Journal of Rheumatology, Arthritis Care & Research, Arthritis & Rheumatism, Rheumatology and Lancet.
Dr. Reed has received many honors and awards including recent election into the Kunkel Society and Arthritis Foundation Career awards as well as two RO1s. She is chair of the Juvenile Myositis Group for the Childhood Arthritis and Rheumatology Research Alliance and past chair of the American Board of Pediatrics sub-board for Rheumatology. She supervises and advises fellows and junior faculty in their clinical and translational research projects, teaching sessions and monthly journal club.
Lauren M. Pachman, MD
Professor of Pediatrics
Northwestern University Feinberg School of Medicine, considers it a privilege and an exciting challenge to provide longitudinal and individualized medical care for more than 20% of the Juvenile Myositis children in the United States. A University of Chicago Medical School graduate, Dr. Pachman received their Distinguished Service Award, the University Alumnae Professional Achievement Award as well as the national award for Clinical Research from the American College of Rheumatology, among others. The author of over 150 peer-reviewed full length scientific publications, Dr. Pachman directs her translational research team who are members of the Cure JM Program of Excellence in JM Research at Children’s Memorial Hospital and Research Center in Chicago. The “frequent flyer” clinic’s comprehensive and coordinated care is supported by a multidisciplinary team of nurses, physical therapists, social workers and pediatric rheumatologists. Dr. Pachman’s team is developing and standardizing new ways to monitor symptoms and signs of disease activity while they are engaged in NIH-sponsored advanced molecular studies of the myositis process.
Lisa G. Rider, M.D.
Deputy Chief of the Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health
Pediatric rheumatologist Dr. Lisa Rider is a consultant /attending physician and Clinical Professor of Medicine at The George Washington University Myositis Center, a Cure JM-funded endeavor. She has been researching JM for more than 17 years and has published 90 peer-reviewed papers. Dr. Rider has been a member of the steering committees for the clinical trial evaluating rituximab in myositis patients, as well as an international study to develop new classification criteria for myositis. Dr. Rider is a contributor and the lead pediatric investigator in the MYOGEN study to identify new genetic risk factors for adult and juvenile dermatomyositis. She co-chairs the International Myositis Assessment and Clinical Studies Group, which is conducting collaborative myositis clinical studies and developing standards for myositis clinical trials. Dr. Rider is the principal investigator of the Childhood Myositis Heterogeneity Study, a national registry that Cure JM has helped support. Dr. Rider also co-edited Myositis and You, a JM guidebook that Cure JM partially funded. Dr. Rider, a Captain, has recently been named Physician Researcher of the Year by the US Public Health Service, in recognition of her substantial basic and clinical research on myositis.